Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Birmingham, Alabama 35205


Purpose:

Primary: We hypothesize a clinically significant improvement in sleep latency, sleep-onset and total sleep time measures in adults with ADHD when given a trial of Ramelteon compared to placebo. Secondary:We expect that Ramelteon will show statistically significant improvements vs. placebo in measures of daytime sleepiness and with no decrement in daytime functioning, including such specific items as focus and social and occupational functioning.


Study summary:

Method: 8-week, randomized, double-blind, placebo-controlled crossover trial of Ramelteon in adult ADHD subjects who suffer from initial insomnia.


Criteria:

Inclusion Criteria: - Diagnosis of ADHD and insomnia- - 19-65 years of age - In good general health - Negative pregnancy test Exclusion Criteria: - Current primary psychiatric diagnosis other than ADHD - Positive urine drug screen for any sedative hypnotic or drugs of abuse - Unstable medical condition - HIV positive - Seizure disorder - Known hypersensitivity to Ramelteon


NCT ID:

NCT00622427


Primary Contact:

N/A


Backup Contact:

N/A


Location Contact:

Birmingham, Alabama 35205
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: June 25, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.